NovaBay Pharmaceuticals, Inc. financial data

Symbol
NBY on NYSE
Industry
Pharmaceutical Preparations
Location
2000 Powell Street, Suite 1150, Emeryville, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 111 % -47.4%
Quick Ratio 17.4 % -76.6%
Debt-to-equity 465 %
Return On Assets -182 % -99.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.89M shares -25.2%
Common Stock, Shares, Outstanding 4.89M shares -25.2%
Entity Public Float 3.05M USD -72%
Common Stock, Value, Issued 49K USD -24.6%
Weighted Average Number of Shares Outstanding, Basic 3.71M shares +2669%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 64K USD -36.6%
Selling and Marketing Expense 5.85M USD +4.19%
General and Administrative Expense 7.56M USD +10.7%
Operating Income (Loss) -9.05M USD +27.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.64M USD +9.13%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.1M USD +26.3%
Earnings Per Share, Basic 52.3 USD/shares +95.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 776K USD -77.7%
Accounts Receivable, after Allowance for Credit Loss, Current 704K USD
Inventory, Net 473K USD -86.5%
Other Assets, Current 116K USD +61.1%
Assets, Current 2.28M USD -72.3%
Property, Plant and Equipment, Net 61K USD -37.1%
Operating Lease, Right-of-Use Asset 1.04M USD -31.7%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 495K USD -1.2%
Assets 3.88M USD -69.8%
Accounts Payable, Current 396K USD -58.2%
Employee-related Liabilities, Current 288K USD -31.8%
Accrued Liabilities, Current 1.15M USD -38.6%
Contract with Customer, Liability, Current 4K USD -92.6%
Liabilities, Current 1.98M USD -56.6%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 821K USD -34%
Liabilities 2.81M USD -51.8%
Retained Earnings (Accumulated Deficit) -182M USD -10%
Stockholders' Equity Attributable to Parent 1.07M USD -84.8%
Liabilities and Equity 3.88M USD -69.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.57M USD -32.4%
Net Cash Provided by (Used in) Financing Activities -597K USD
Net Cash Provided by (Used in) Investing Activities 1.07M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 4.89M shares -25.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD +19.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25M USD -65.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 236K USD
Deferred Tax Assets, Valuation Allowance 41M USD +9.66%
Deferred Tax Assets, Gross 41.4M USD +9.18%
Operating Lease, Liability 1.21M USD -30%
Depreciation 44K USD -30.8%
Payments to Acquire Property, Plant, and Equipment 2K USD -84.6%
Lessee, Operating Lease, Liability, to be Paid 1.29M USD -31.2%
Property, Plant and Equipment, Gross 743K USD -1.98%
Operating Lease, Liability, Current 390K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 444K USD +1.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 439K USD -21.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 79K USD -46.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 290K USD -34.7%
Deferred Tax Assets, Operating Loss Carryforwards 36.9M USD +4.85%
Preferred Stock, Shares Issued 1 shares
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 974K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 290K USD -34.7%
Operating Lease, Payments 552K USD +24.9%
Additional Paid in Capital 183M USD +7.38%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 152K USD -58.1%
Depreciation, Depletion and Amortization 51K USD -57.5%
Share-based Payment Arrangement, Expense 227K USD -22%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares